We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Price to earnings forward of BrainStorm Cell Therapeutics Inc. – OTC:BCLI - TradingView
Price to earnings forward of BrainStorm Cell Therapeutics Inc. – OTC:BCLI TradingView
The Escalator: VML Health, BrainStorm Cell Therapeutics, Syneos Health and more - Medical Marketing and Media
The Escalator: VML Health, BrainStorm Cell Therapeutics, Syneos Health and more Medical Marketing and Media
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PR Newswire
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine PR Newswire
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 14. | After market close (AMC) | $-0.29 | — | — | $0 | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2024. 07. 11. | Maxim Group | — | Upgrade | Hold → Buy | — | Maxim Group: Hold → Buy |
| 2023. 09. 28. | Maxim Group | — | Downgrade | Buy → Hold | — | Maxim Group: Buy → Hold |
| 2023. 03. 31. | Maxim Group | — | Maintain | — → Buy | — | Maxim Group: Buy |
| 2021. 02. 05. | Maxim Group | — | Upgrade | Hold → Buy | — | Maxim Group: Hold → Buy |
| 2018. 05. 15. | HC Wainwright & Co. | — | Initiate coverage | — → Buy | — | HC Wainwright & Co.: Buy |
| 2017. 08. 18. | Maxim Group | — | Maintain | — → Buy | — | Maxim Group: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.